Hereditary Angioedema Types I and II
"Hereditary Angioedema Types I and II" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.
| Descriptor ID |
D056829
|
| MeSH Number(s) |
C14.907.079.500.750 C17.800.862.945.066.500.750 C20.543.480.904.066.500.750
|
| Concept/Terms |
Hereditary Angioedema Types I and II- Hereditary Angioedema Types I and II
- C1 Esterase Inhibitor, Deficiency Of
- Hereditary Angioedema Type 1
- Angioedema, Hereditary, Types I and II
- Deficiency of C1 Esterase Inhibitor
|
Below are MeSH descriptors whose meaning is more general than "Hereditary Angioedema Types I and II".
Below are MeSH descriptors whose meaning is more specific than "Hereditary Angioedema Types I and II".
This graph shows the total number of publications written about "Hereditary Angioedema Types I and II" by people in this website by year, and whether "Hereditary Angioedema Types I and II" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hereditary Angioedema Types I and II" by people in Profiles.
-
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial. JAMA. 2018 11 27; 320(20):2108-2121.
-
Endocan: A Novel Marker of Endothelial Dysfunction in C1-Inhibitor-Deficient Hereditary Angioedema. Int Arch Allergy Immunol. 2017; 174(2):104-107.
-
Patient satisfaction and experience with intravenously administered C1-inhibitor concentrates in the United States. Ann Allergy Asthma Immunol. 2017 07; 119(1):59-64.
-
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140.